Eitan Yudilevich
Executive @ BIRD Foundation
Eitan Yudilevich is a grant investor at BIRD Foundation focused on Manufacturing and Medical. Dr. Eitan Yudilevich completed his doctoral studies in computers and systems engineering in the field of medical imaging in the Department of Electrical, Computer, and Systems Engineering at Rensselaer Polytechnic Institute. He earned his Master's Degree in mathematics at the Rensselaer Polytechnic Institute, and his Bachelor's andMaster's Degrees in electrical engineering at Haifa's Technion. Dr. Yudilevich assumed the Executive Director position at the BIRD Foundation on January 1, 2006. In his first year of tenure, BIRD’s Board of Governors approved 25 new joint U.S.-Israeli company-to-company projects
- Total investments:
- 28
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Eitan Yudilevich invests in
Stages Eitan Yudilevich invests in
Countries Eitan Yudilevich invests in
Investment Focus
Industry
- Manufacturing 11 (39%)
- Medical 5 (18%)
- Energy 4 (14%)
- Battery 3 (11%)
- Automotive 3 (11%)
Country
- United States 14 (50%)
- Israel 10 (36%)
- China 1 (4%)
- Austria 1 (4%)
- Switzerland 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
EyeControl
|
EyeControl is a pioneer of medical technology, specializing in innovative communication solutions that address unmet healthcare needs. We implement disruptive AI-technologies that connect people and bridge information barriers, facilitating better medical care and decision-making. Our eye-tracking wearable and smart platforms empowercomprehensive, round-the-clock, bi-directional connectivity between patients with communication difficulties, their families, and medical teams. Using adaptive, ML-based pattern recognition, eye gestures are analyzed and converted to real-time communication and actionable clinical data for patients with various levels of cognition. Established in 2016 by individuals, who share unique personal connections to Locked-in patients, EyeControl is a privately held, rapidly growing startup. Recognized as spearheads of cutting-edge medical innovation, the company is supported by the European Innovation Council, Israel Innovation Authority, investors and advisors representing various sectors.The EyeControl device is FDA listed, CE marked, ISO certified, AMAR registered, and HIPAA compliant; it is federally reimbursed in Israel, the UK, and the US. Clinical trials validating its efficacy in detecting and mitigating Delirium are underway in Israel and the US. | Grant / Jan 19, 2023 | |
Ultraflex Power Technologies, Inc
|
Ultraflex Power Technologies in a manufacturer of induction heating and induction melting systems | Grant / Jan 19, 2023 | |
iTolerance
|
iTolerance is a biotechnology company focused on regenerative medicine without immunosuppression. The company was founded in 2020 and is headquartered in Santa Barbara, CA. | Grant / Jan 19, 2023 | |
Beth Israel Deaconess Medical Center
|
A teaching hospital of Harvard Medical School, Beth Israel Deaconess Medical Center is renowned for excellence in patient care, biomedical research, teaching and community service. Located in the heart of Boston's medical community, it hosts nearly three quarters of a million patient visits annually in and around Boston. | Grant / Jan 19, 2023 | |
Hellbender
|
Hellbender develops and manufactures lot and robotic products. | Grant / Jan 19, 2023 | |
Guinn Partners
|
Guinn Partners engages with visionary brands in the drones, technology, and outdoor sporting goods spaces with best in class marketing. | Grant / Jan 19, 2023 | |
Castor Technologies LTD
|
CASTOR’s proprietary technology helps manufacturers assess how to apply advanced manufacturing to their production processes. By providing a comprehensive technical and cost-savings assessment for a full bill of materials, designers, NPI managers and production engineers have the critical information they need to effectively and efficiently makemachine parts. | Grant / Jan 19, 2023 | |
Setco
|
Setco is a manufacturing company that produces precision spindles, milling heads, slides, precision machining and patented products. | Grant / Jan 19, 2023 | |
New Phase
|
New Phase is a nanomedical tech firm that treats metastatic solid tumors through thermal energy causing death to the malignant cell. New Phase captures expertise and knowledge within the field of magnetic fluid hyperthermia. | Grant / Jan 19, 2023 | |
Al Cielo
|
Cielo specializes in the research, development, manufacturing and integration of laser technologies and navigation and control inertial sensors.With over 40 patents, world class facilities and a decade of experience in development and manufacturing of electro and fiber optical systems, Al Cielo brings measurable advantages to Fiber OpticGyroscopes (FOG), Inertial Measurement Units (IMU) and Inertial Navigation Systems (INS). Al Cielo is the prime local supplier in Israel for closed loop FOGs sensors technology engaged in a wide variety of navigation and control applications. | Grant / Jan 19, 2023 | |
| See all 28 investments → | |||
About BIRD Foundation
The BIRD (Binational Industrial Research and Development) Foundation works to encourage and facilitate cooperation between U.S. and Israeli companies in a wide range of technology sectors and offers funding to selected projects. BIRD has approved close to 950 projects over its 40-year history.The BIRD Foundation supports projects withoutreceiving any equity or intellectual property rights in the participating companies or in the projects, themselves. BIRD funding is repaid as royalties from sales of products that were commercialized as a result of BIRD support. The Foundation provides funding of up to 50% of a project's budget, beginning with R&D and ending with the initial stages of sales and marketing. The Foundation shares the risk and does not require repayment if the project fails to reach the sales stage.
BIRD Foundation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Eitan Yudilevich
Executive
|
|||
|
Shlomo Cohen
CFO
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Eitan Yudilevich invest in?
Eitan Yudilevich invests primarily in Manufacturing, Medical and Energy startups, most often at Grant stage. Most of the 28 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Eitan Yudilevich last invest?
The most recent investment recorded for Eitan Yudilevich closed in Jan 2023. Shizune tracks 28 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
